Evidence map›Paper›PMID 39999880›Full record

ArticleJournal of the Royal Society, Interface2025

Hierarchical TiO

Nur Kubra Tasdemir, Bogac Kilicarslan, Gozde Imren, Beren Karaosmanoglu, Ekim Z Taskiran, Cem Bayram

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of the Royal Society, Interface, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Hierarchical TiOJournal of the Royal Society, Interface · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Nur Kubra TasdemirDepartment of Medical and Surgical Research, Hacettepe University, Institute of Health Sciences, Ankara, Turkey.
Bogac KilicarslanDepartment of Nanotechnology and Nanomedicine, Graduate School of Science and Engineering, Hacettepe University, Ankara, Turkey.
Gozde ImrenDepartment of Medical and Surgical Research, Hacettepe University, Institute of Health Sciences, Ankara, Turkey.
Beren KaraosmanogluDepartment of Medical Genetics, Faculty of Medicine, Hacettepe University, Ankara, Turkey.ORCID 0000-0001-5564-4813
Ekim Z TaskiranDepartment of Medical and Surgical Research, Hacettepe University, Institute of Health Sciences, Ankara, Turkey.ORCID 0000-0001-6040-6625
Cem BayramDepartment of Nanotechnology and Nanomedicine, Graduate School of Science and Engineering, Hacettepe University, Ankara, Turkey.ORCID 0000-0001-8717-4668

Funding

Hacettepe University Scientific Research Projects Unit
6 · The paper itself

Abstract

The concept of preconditioning mesenchymal stem cells (MSCs) under different stress conditions or with bioactive molecules is introduced to optimize their therapeutic potential. This study investigates the physicochemical effect of hierarchical TiO

Indexed as

Mesenchymal Stem CellsNanotubesTitaniumCell AdhesionCell DifferentiationCell ProliferationHumansReceptors, CXCR4Surface PropertiesVascular Endothelial Growth Factor ACXCR4 protein, humanReceptors, CXCR4Titaniumtitanium dioxideVascular Endothelial Growth Factor AVEGFA protein, humanelectrochemical anodizationmesenchymal stem cellsnanotopographyregenerative medicinetissue engineeringtitanium dioxide

Identifiers

PMID39999880
PMCPMC11858746

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.